SCHEMBL565580

SCHEMBL565580

Cc1cc(=O)oc2c(F)c(O)c(F)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 9/20 0.55
KDM4E B2RXH2 8/20 0.53
GAA P10253 6/20 0.53
ALDH1A1 P00352 6/20 0.53
CYP3A4 P08684 3/20 0.53
MAPT P10636 2/20 0.53
MAPK1 P28482 2/20 0.53
LMNA P02545 2/20 0.53
MGAM O43451 1/20 0.53
TP53 P04637 1/20 0.53
SI P14410 1/20 0.53
ALOX15 P16050 1/20 0.53
MGAM2 Q2M2H8 1/20 0.53
MAOB P27338 3/20 0.49
HSD17B10 Q99714 4/20 0.48
UBE2N P61088 1/20 0.48
GLA P06280 4/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29391372 1.00 MCL1 (0.55) MCL1KDM4EGAAALDH1A1CYP3A4
Phosphoric Acid SCHEMBL1934555 0.94 MCL1 (0.50) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL22840385 0.87 KDM4E (0.58) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL27739749 0.84 KDM4E (0.58) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL8571050 0.83 MET (0.51) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL14924918 0.83 ERN1 (0.60) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL17716516 0.81 KDM4E (0.48) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL17716520 0.81 MCL1 (0.50) MCL1KDM4EGAAALDH1A1CYP3A4
SCHEMBL13177605 0.78 KDM4E (0.48) KDM4EGAAALDH1A1MAPTMAPK1
SCHEMBL10265067 0.78 MAOA (0.52) MCL1KDM4EGAAALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731992-A1 GREEN ENERGY SOURCES AUTHENTICATION AND COMPLIANCE TESTING Authentix, Inc. (US) 2026-04-29 EP claimed
EP-4313156-B1 DISULFIDE-BASED PRODRUG COMPOUNDS UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2025-08-06 EP claimed
WO-2025050003-A1 HIGH-THROUGHPUT CONDENSATE MODULATOR SCREEN TRANSITION BIO, INC. (US) 2025-03-06 WO claimed
WO-2025042992-A1 GREEN ENERGY SOURCES AUTHENTICATION AND COMPLIANCE TESTING AUTHENTIX, INC. (US) 2025-02-27 WO claimed
US-20240207414-A1 DISULFIDE-BASED PRODRUG COMPOUND LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2024-06-27 US claimed
US-20240168032-A1 GLUCOSE BIOSENSORS AND USES THEREOF UNIV DUKE (US) 2024-05-23 US claimed
US-20240156965-A1 DICHALCOGENIDE PRODRUGS LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2024-05-16 US claimed
EP-3377898-B1 THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF UNIV DUKE (US) 2024-05-01 EP claimed
EP-3377897-B1 LACTATE BIOSENSORS AND USES THEREOF UNIV DUKE (US) 2024-05-01 EP claimed
EP-3377904-B1 UREA BIOSENSORS AND USES THEREOF UNIV DUKE (US) 2024-05-01 EP claimed
EP-3377897-A1 LACTATE BIOSENSORS AND USES THEREOF Duke University (US) 2018-09-26 EP claimed
EP-3377904-A2 UREA BIOSENSORS AND USES THEREOF Duke University (US) 2018-09-26 EP claimed
EP-3377898-A2 THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF Duke University (US) 2018-09-26 EP claimed
EP-3377899-A2 BICARBONATE BIOSENSORS, CALCIUM BIOSENSORS, AND USES THEREOF Duke University (US) 2018-09-26 EP claimed
EP-3377643-A1 GLUCOSE BIOSENSORS AND USES THEREOF Duke University (US) 2018-09-26 EP claimed
US-9902986-B2 Enterobactin conjugates and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-02-27 US claimed
US-20180000704-A1 USES OF CO-CRYSTALS UNIV STRATHCLYDE (GB) 2018-01-04 US claimed
EP-3250643-A1 USES OF CO-CRYSTALS University of Strathclyde (GB) 2017-12-06 EP claimed
WO-2016120642-A1 USES OF CO-CRYSTALS UNIVERSITY OF STRATHCLYDE (GB) 2016-08-04 WO claimed
US-5968762-A MIXING SAMPLE AND CONJUGATE OF FLUORESCENT MOIETY COVALENTLY LINKED TO BACTERIAL NUTRIENT THROUGH BOND HYDROLYZABLE BY BACTERIA, INDUCING AND DETECTING FLUORESCENCE EMISSION OF CONJUGATATE AND RELEASED MOIETY, CALCULATING RATIO THE UNIVERSITY OF CONNECTICUT (US) 1999-10-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207414-A1 DISULFIDE-BASED PRODRUG COMPOUND CBS, MSR1, P4HB MCL1 247/4885KDM4E 4718/4885GAA 2029/4885
US-20240156965-A1 DICHALCOGENIDE PRODRUGS DHCR7, DECR1, CYP27A1 MCL1 793/4885KDM4E 4690/4885GAA 1631/4885
US-20240168032-A1 GLUCOSE BIOSENSORS AND USES THEREOF GCK, GCKR, SLC2A4 MCL1 4018/4885KDM4E 3773/4885GAA 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.